SCHEMBL6286427

SCHEMBL6286427

Cn1c2ccccc2c2cccc(N)c21

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALKBH5 Q6P6C2 1/20 0.63
FTO Q9C0B1 1/20 0.63
GPR3 P46089 1/20 0.58
LIMK1 P53667 1/20 0.49
PABPC1 P11940 1/20 0.47
KDM4E B2RXH2 4/20 0.47
MAPT P10636 3/20 0.47
HSP90AA1 P07900 1/20 0.46
IDO1 P14902 1/20 0.46
ALDH1A1 P00352 4/20 0.43
HPGD P15428 4/20 0.43
HSD17B10 Q99714 4/20 0.43
LMNA P02545 1/20 0.43
GLA P06280 1/20 0.43
GAA P10253 1/20 0.43
GABRP O00591 1/20 0.41
GABRD O14764 1/20 0.41
GABRA1 P14867 1/20 0.41
GABRB1 P18505 1/20 0.41
GABRG2 P18507 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23308373 0.85 HCRTR1 (0.49) ALKBH5FTOGPR3LIMK1KDM4E
SCHEMBL29032554 0.82 ALKBH5 (0.43) ALKBH5FTOGPR3LIMK1PABPC1
SCHEMBL3875043 0.81 ALKBH5 (0.55) ALKBH5FTOGPR3LIMK1PABPC1
SCHEMBL3423943 0.81 GPR3 (0.71) ALKBH5FTOGPR3LIMK1KDM4E
SCHEMBL13564071 0.81 GPR3 (0.71) ALKBH5FTOGPR3LIMK1KDM4E
SCHEMBL3882799 0.79 GPR3 (0.52) ALKBH5FTOGPR3LIMK1PABPC1
SCHEMBL1181056 0.79 ALKBH5 (0.58) ALKBH5FTOGPR3LIMK1PABPC1
SCHEMBL16376466 0.79 ALKBH5 (0.68) ALKBH5FTOGPR3LIMK1KDM4E
SCHEMBL3873231 0.78 KDM4E (0.55) ALKBH5FTOGPR3LIMK1PABPC1
SCHEMBL23346969 0.78 ALKBH5 (0.51) ALKBH5FTOGPR3LIMK1PABPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112300124-B Organic electroluminescent device and organometallic complex for organic electroluminescent device 三星显示有限公司 2025-02-21 CN disclosed
EP-4272832-A2 ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF Lakewood Amedex, Inc. (US) 2023-11-08 EP disclosed
US-20230322831-A1 LIGHT-EMITTING DEVICE INCLUDING ORGANOMETALLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE ORGANOMETALLIC COMPOUND SAMSUNG DISPLAY CO., LTD. (KR) 2023-10-12 US disclosed
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2023-07-04 US disclosed
WO-2021128126-A1 ALPHA-OLEFIN INTERPOLYMERS WITH IMPROVED MOLECULAR DESIGN FOR PHOTOVOLTAIC ENCAPSULANTS DOW GLOBAL TECHNOLOGIES LLC (US) 2021-07-01 WO disclosed
US-20210139522-A1 ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF Lakewood Amedex, Inc. 2021-05-13 US disclosed
CN-112300124-A Organic electroluminescent device and organic metal complex used for organic electroluminescent device 三星显示有限公司 2021-02-02 CN disclosed
EP-2977378-B1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO LTD (KR) 2020-06-10 EP disclosed
US-6965037-B2 Method for producing aminocarbazoles SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2005-11-15 US disclosed
US-20020183526-A1 Method for producing aminocarbazoles KAMIKAWA TAKASHI (JP) 2002-12-05 US disclosed
US-20010049448-A1 METHOD FOR PRODUCING AMINOCARBAZOLES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2001-12-06 US disclosed
EP-0485455-A1 THERMALLY STABLE CARBAZOLE DIAZONIUM SALTS AS SOURCES OF PHOTO-INITIATED STRONG ACID E.I. DU PONT DE NEMOURS AND COMPANY (US) 1992-05-20 EP disclosed
US-5002856-A Diazonium salts as photoinitiators, glycidyl polymers for development E. I. DU PONT DE NEMOURS AND COMPANY (US) 1991-03-26 US disclosed
WO-1991002288-A1 THERMALLY STABLE CARBAZOLE DIAZONIUM SALTS AS SOURCES OF PHOTO-INITIATED STRONG ACID E.I. DU PONT DE NEMOURS AND COMPANY (US) 1991-02-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230322831-A1 LIGHT-EMITTING DEVICE INCLUDING ORGANOMETALLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE ORGANOMETALLIC COMPOUND CRY1, LAGE3, LIG1 ALKBH5 2587/4885FTO 562/4885GPR3 4053/4885
US-20210139522-A1 ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF CFTR, ABCB11, CEL ALKBH5 4092/4885FTO 4532/4885GPR3 4243/4885
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes KCNQ2, KCNQ1, KCNQ4 ALKBH5 1460/4885FTO 187/4885GPR3 1210/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.